VEGFA and retinopathy of prematurity: Analysis of 3787 eyes from 5 RCTs and 12 observational studies showed that anti‐VEGF therapy significantly reduced the need for surgical interventions in infants with ROP (RR 0.38; 95% CI 0.22–0.65; Figure 4).